作者: Michael S Kostapanos , Evangelos N Liberopoulos , Moses S Elisaf , None
DOI: 10.1111/J.1559-4572.2008.00052.X
关键词: Obstructive Nephropathy 、 Glomerulosclerosis 、 Kidney 、 Mesangial cell 、 Endocrinology 、 Pharmacology 、 Pleiotropy (drugs) 、 Internal medicine 、 Glomerulonephritis 、 Medicine 、 Statin 、 Renal function
摘要: Statins may exhibit significant renoprotective effects beyond their lipid-lowering capacity. Herein, the authors review data from human and animal models of renal disease as well studies in cultured cells with regard to extralipid properties statins. exert lipid-independent benefits against injury experimental states chronic or acute function impairment. These include diabetic hypertensive glomerulosclerosis, autoimmune glomerulonephritis, ischemia/reperfusion-induced damage, unilateral ureteral obstructive nephropathy. Also, statins, by reducing synthesis mevalonate products, inhibit activation Rho Ras guanosine triphosphatases that influence various signaling pathways involving inflammatory, fibrogenic, proliferative, cell-death responses. Therefore, statins anti-inflammatory actions tissue, prevent scarring, diminish mesangial other kidney cell-type proliferation while promoting cell apoptosis. Renal antioxidant consequent endothelial regulation vasculature following statin treatment also account for pleiotropic protection injury.